# Reproducibility of an Immobilization Device (BodyFIX) - Hodgkins/Lymphoma

> **NCT00232440** · PHASE1,PHASE2 · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 20 (—)

## Conditions studied

- Hodgkin's Disease
- Lymphoma, Non-Hodgkin

## Interventions

- **DEVICE:** BodyFIX

## Key facts

- **NCT ID:** NCT00232440
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-01
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 20 (—)
- **Last updated:** 2010-08-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00232440

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00232440, "Reproducibility of an Immobilization Device (BodyFIX) - Hodgkins/Lymphoma". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00232440. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*